# FMT-LUMINATE (NCT04951583)

> Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04951583
- Phase: PHASE2
- Status: UNKNOWN
- Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
- Conditions: Non Small Cell Lung Cancer Metastatic; Advanced Melanoma
- Interventions: FMT + ICI
- Enrollment: 45
- Primary outcome: Objective response rate in the NSCLC cohort by RECIST criteria.

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 11
- Podcasts: 2
- Bluesky threads: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=fmt-luminate-nct04951583

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04951583", "email": "<work email>"}; the inbox owner confirms by the emailed link.